Huichuan Sun

10PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2026
Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization.

|Nov 04, 2024
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis.

Peiyi Xie, Lei Guo, Qiang Yu

|Feb 15, 2023
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study.

Ming-Hao Xu, Cheng Huang, Mei-Ling Li

|Aug 06, 2021
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.

Jianming Xu, Yuxian Bai, Huichuan Sun

|Jul 05, 2021
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure.

Bin Xu, Xiao-Long Li, Feng Ye

|Jun 11, 2021
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma.

Nan Xiao, Xiaodong Zhu, Kangshuai Li

Pageof 2

Frequent Collaborators

3 joint publications

Jian Zhou

3 joint publications

Jia Fan

2 joint publications

Ying-Hao Shen

1 joint publications

Bin Xu